Jeri Matera - Concepedia

Concepedia

Author

Jeri Matera

Eon Corporation (United States)

Also Known As

J Matera, J. Matera, J. R. Matera, Jeri Matera

22

Publications

10.3K

Citations

10

H-Index

20

Concepts

All Affiliations

Eon Corporation (United States)Cleveland Clinic The University of Texas MD Anderson Cancer Center University of Arizona Washington University in St. Louis

JM

About

Jeri Matera is an author at Eon Corporation (United States) specializing in medicine, oncology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	322
2	Pathology	4	4	228
3	Cell Biology	3	3	215
4	Immunology	2	2	26
5	Health Sciences	1	1	13

Jeri Matera

×

10

Publications

10.3K

Citations

10

H-Index

	Year	Citations
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis, New England Journal of Medicine	2004	4.5K
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases W. Jeffrey Allard, Jeri Matera, Michael Craig Miller, Clinical Cancer Research	2004	2.5K
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer Massimo Cristofanilli, Daniel F. Hayes, G. Thomas Budd, Journal of Clinical Oncology	2005	1.1K
Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival Daniel F. Hayes, Massimo Cristofanilli, G. Thomas Budd, Clinical Cancer Research	2006	1K
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer G. Thomas Budd, Massimo Cristofanilli, Mathew J. Ellis, Clinical Cancer Research	2006	787
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases W. Jeffrey Allard, Jeri Matera, Michael Craig Miller, Journal of Clinical Oncology Healthy SubjectsOncologic ImagingBlood CellPathologyPeripheral Blood	2004	164
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer José Baselga, Alexey Manikhas, Javier Cortés, Annals of Oncology Breast OncologyNonpegylated Liposomal DoxorubicinMedicinePharmacologyPhase Iii Trial	2014	94
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases W. Jeffrey Allard, Jeri Matera, Michael Craig Miller, Journal of Clinical Oncology Healthy SubjectsOncologic ImagingBlood CellPathologyPeripheral Blood	2004	38
Presence of circulating tumor cells (CTC) in metastatic breast cancer (MBC) predicts rapid progression and poor prognosis Massimo Cristofanilli, G. T. Budd, Matthew J. Ellis, Journal of Clinical Oncology Breast OncologyCancer ManagementImmunologyPathologyCancer Biology	2005	13
Monitoring circulating tumor cells (CTC) in non-measurable metastatic breast cancer (MBC) G. T. Budd, Massimo Cristofanilli, Matthew J. Ellis, Journal of Clinical Oncology Breast OncologyOncologic ImagingCancer ManagementImmunologyPathology	2005	13

Page 1